Efficacy of Intravenous Tranexamic Acid in Reducing Blood Loss after Elective Cesarean Section: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

 

 Buy Article Permissions and Reprints

ABSTRACT

We sought to determine the efficacy and safety of tranexamic acid (TA) in reducing blood loss during elective cesarean section (CS). We performed a randomized, double-blind, placebo-controlled study of 660 women who underwent elective CS. The patients were randomly selected to receive an intravenous infusion of either TA (1 g/10 mL in 20 mL of 5% glucose; n = 330) or 30 mL 5% glucose prior to surgery. The primary outcome was the estimated blood loss following CS. No demographic difference was observed between groups. The mean estimated blood loss was significantly lower in women treated with TA compared with women in the placebo group (499.9 ± 206.4 mL versus 600.7 ± 215.7 mL, respectively; p < 0.001), and the proportion of women in the TA group who had an estimated blood loss >1000 mL was significantly lower than in the placebo group (7 [2.1%] versus 19 [5.8%], respectively; relative risk [RR] 2.7; 95% confidence interval [CI] 1.1 to 6.3; p < 0.03). Furthermore, more women in the placebo group than in the TA group required additional uterotonic agents (48 [14.5%] versus 28 [8.5%], respectively; RR 1.7; 95% CI 1.1 to 2.6; p = 0.02). Maternal and neonatal outcomes did not differ significantly. TA significantly reduced bleeding during CS, the percentage of patients with blood loss >1000 mL, and the need for additional uterotonic agents. Furthermore, the incidence of thromboembolic events did not increase. Our results suggest that TA can be used safely and effectively to reduce CS bleeding.

REFERENCES

• 1 Magann E F, Evans S, Hutchinson M, Collins R, Lanneau G, Morrison J C. Postpartum hemorrhage after cesarean delivery: an analysis of risk factors.  South Med J. 2005;  98 681-685
  CrossrefPubMedGoogle Scholar
• 2 Güngördük K, Asicioglu O, Celikkol O, Olgac Y, Ark C. Use of additional oxytocin to reduce blood loss at elective caesarean section: a randomised control trial.  Aust N Z J Obstet Gynaecol. 2010;  50 36-39
  CrossrefPubMedGoogle Scholar
• 3 Ahmed B, Abu Nahia F, Abushama M. Routine cervical dilatation during elective cesarean section and its influence on maternal morbidity: a randomized controlled study.  J Perinat Med. 2005;  33 510-513
  CrossrefPubMedGoogle Scholar
• 4 Caesarean Section .Clinical Guideline. National Collaborating Centre for Women's and Children's Health. London: RCOG Press; 2004
  Google Scholar
• 5 Bolton T J, Randall K, Yentis S M. Effect of the confidential enquiries into maternal deaths on the use of syntocinon at caesarean section in the UK.  Anaesthesia. 2003;  58 277-279
  CrossrefPubMedGoogle Scholar
• 6 Prentice A. Fortnightly review. Medical management of menorrhagia.  BMJ. 1999;  319 1343-1345
  CrossrefPubMedGoogle Scholar
• 7 Gleeson N C, Buggy F, Sheppard B L, Bonnar J. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.  Acta Obstet Gynecol Scand. 1994;  73 274-277
  CrossrefPubMedGoogle Scholar
• 8 Dunn C J, Goa K L. Tranexamic acid: a review of its use in surgery and other indications.  Drugs. 1999;  57 1005-1032
  CrossrefPubMedGoogle Scholar
• 9 Novikova N, Hofmeyr G J. Tranexamic acid for preventing postpartum haemorrhage.  Cochrane Database Syst Rev. 2010;  7 CD007872
  PubMedGoogle Scholar
• 10 As A K, Hagen P, Webb J B. Tranexamic acid in the management of postpartum haemorrhage.  Br J Obstet Gynaecol. 1996;  103 1250-1251
  CrossrefPubMedGoogle Scholar
• 11 Gai M Y, Wu L F, Su Q F, Tatsumoto K. Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial.  Eur J Obstet Gynecol Reprod Biol. 2004;  112 154-157
  CrossrefPubMedGoogle Scholar
• 12 Gohel M, Patel P, Gupta A, Desai P. Efficacy of tranexamic acid in decreasing blood loss during and after caesarean section: a randomized case controlled prospective study.  J Obstet Gynaecol India. 2007;  57 228-230
  PubMedGoogle Scholar
• 13 Sekhavat L, Tabatabaii A, Dalili M, Farajkhoda T, Tafti A D. Efficacy of tranexamic acid in reducing blood loss after cesarean section.  J Matern Fetal Neonatal Med. 2009;  22 72-75
  PubMedGoogle Scholar
• 14 Shook P R, Schultz J R, Reynolds J D, Spahn T E, DeBalli P. Estimating blood loss for cesarean section: how accurate are we?.  Anesthesiology. 2003;  98 (Suppl) A1
  CrossrefPubMedGoogle Scholar
• 15 Ferrer P, Roberts I, Sydenham E, Blackhall K, Shakur H. Anti-fibrinolytic agents in post partum haemorrhage: a systematic review.  BMC Pregnancy Childbirth. 2009;  9 29
  CrossrefPubMedGoogle Scholar
• 16 Stafford I, Dildy G A, Clark S L, Belfort M A. Visually estimated and calculated blood loss in vaginal and cesarean delivery.  Am J Obstet Gynecol. 2008;  199 519.e1-519.e7
  CrossrefPubMedGoogle Scholar
• 17 Wellington K, Wagstaff A J. Tranexamic acid: a review of its use in the management of menorrhagia.  Drugs. 2003;  63 1417-1433
  CrossrefPubMedGoogle Scholar
• 18 Fiechtner B K, Nuttall G A, Johnson M E et al.. Plasma tranexamic acid concentrations during cardiopulmonary bypass.  Anesth Analg. 2001;  92 1131-1136
  PubMedGoogle Scholar
• 19 Henry D A, Moxey A J, Carless P A et al.. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.  Cochrane Database Syst Rev. 2001;  (1) CD001886
  PubMedGoogle Scholar
• 20 Mousa H A, Alfirevic Z. Major postpartum hemorrhage: survey of maternity units in the United Kingdom.  Acta Obstet Gynecol Scand. 2002;  81 727-730
  CrossrefPubMedGoogle Scholar

Kemal GungordukM.D. 

Department of Obstetrics and Gynecology

Mardin Women and Children Hospital, Mardin, Turkey

Email: maidenkemal@yahoo.com